IL133578A - Derivatives of aryl carboxylic acid and aryl tetrazole, and pharmaceutical preparations containing them and processes for their preparation - Google Patents

Derivatives of aryl carboxylic acid and aryl tetrazole, and pharmaceutical preparations containing them and processes for their preparation

Info

Publication number
IL133578A
IL133578A IL13357899A IL13357899A IL133578A IL 133578 A IL133578 A IL 133578A IL 13357899 A IL13357899 A IL 13357899A IL 13357899 A IL13357899 A IL 13357899A IL 133578 A IL133578 A IL 133578A
Authority
IL
Israel
Prior art keywords
compound
acetic acid
independently
compound according
acid
Prior art date
Application number
IL13357899A
Other languages
English (en)
Hebrew (he)
Other versions
IL133578A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL133578A0 publication Critical patent/IL133578A0/xx
Publication of IL133578A publication Critical patent/IL133578A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
IL13357899A 1998-12-23 1999-12-17 Derivatives of aryl carboxylic acid and aryl tetrazole, and pharmaceutical preparations containing them and processes for their preparation IL133578A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11344698P 1998-12-23 1998-12-23
US15181499P 1999-08-30 1999-08-30

Publications (2)

Publication Number Publication Date
IL133578A0 IL133578A0 (en) 2001-04-30
IL133578A true IL133578A (en) 2004-07-25

Family

ID=26811078

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13357899A IL133578A (en) 1998-12-23 1999-12-17 Derivatives of aryl carboxylic acid and aryl tetrazole, and pharmaceutical preparations containing them and processes for their preparation

Country Status (29)

Country Link
US (1) US6335459B1 (da)
EP (1) EP1013639B1 (da)
JP (1) JP3415085B2 (da)
KR (1) KR100378335B1 (da)
CN (1) CN1167670C (da)
AR (1) AR029320A1 (da)
AT (1) ATE251125T1 (da)
AU (1) AU735640B2 (da)
BR (1) BR9905974A (da)
CA (1) CA2292921C (da)
DE (1) DE69911726T2 (da)
DK (1) DK1013639T3 (da)
ES (1) ES2207108T3 (da)
HR (1) HRP990394A2 (da)
HU (1) HUP9904659A3 (da)
ID (1) ID25983A (da)
IL (1) IL133578A (da)
MA (1) MA26713A1 (da)
NO (1) NO316171B1 (da)
NZ (1) NZ501891A (da)
PE (1) PE20001368A1 (da)
PL (1) PL337419A1 (da)
PT (1) PT1013639E (da)
RU (1) RU2179969C2 (da)
SG (1) SG90086A1 (da)
TR (1) TR199903310A3 (da)
TW (1) TWI221834B (da)
UY (1) UY25876A1 (da)
YU (1) YU69699A (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828442D0 (en) 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
SE0100158D0 (sv) * 2001-01-19 2001-01-19 Synphora Ab Novel method and composition for local treatment of Meniere´s disease and tinnitus
MXPA03007864A (es) * 2001-03-02 2003-12-04 Hoffmann La Roche Derivados del acido alcoxicarbonilamino-heteroaril carboxilico como antagonistas ip.
ES2636943T3 (es) 2003-05-09 2017-10-10 Toray Industries, Inc. Beraprost y un inhibidor del sistema renina-angiotensina para usar en el tratamiento de enfermedades renales
UA93548C2 (uk) 2006-05-05 2011-02-25 Айерем Елелсі Сполуки та композиції як модулятори хеджхогівського сигнального шляху
US9669381B2 (en) 2007-06-27 2017-06-06 Hrd Corporation System and process for hydrocracking
ES2875944T3 (es) 2008-03-18 2021-11-11 Arena Pharm Inc Moduladores del receptor de prostaciclina (PG12) útiles para el tratamiento de trastornos relacionados con el mismo
MY163762A (en) 2008-07-23 2017-10-31 Toray Industries Therapeutic agent for chronic renal failure
WO2011154826A1 (en) 2010-06-11 2011-12-15 Rhodes Technologies Process for n-dealkylation of tertiary amines
AU2011263417B2 (en) 2010-06-11 2014-03-27 Rhodes Technologies Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof
AU2018227842B2 (en) 2017-03-01 2024-05-02 Arena Pharmaceuticals, Inc. Compositions comprising PGI2-receptor agonists and processes for the preparation thereof
IL314717A (en) 2022-02-15 2024-10-01 United Therapeutics Corp Crystalline prostacyclin (IP) receptor agonist and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1079414A (en) 1965-06-30 1967-08-16 Smith & Nephew Derivatives of acetic acid and a process for their preparation
GB1185539A (en) 1967-11-03 1970-03-25 Smith & Nephew Substituted Tetrazoles
DE2432560A1 (de) 1974-07-06 1976-01-22 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeurederivate und verfahren zur herstellung derselben
JPS5832859A (ja) 1981-08-20 1983-02-25 Dainippon Pharmaceut Co Ltd N,n−ジメチルカルバミン酸ベンジルエステル誘導体
JPH0725725B2 (ja) 1987-07-23 1995-03-22 保土谷化学工業株式会社 ベンズアミド誘導体
US5084466A (en) 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
CA2090283A1 (en) 1992-02-28 1993-08-29 Nobuyuki Hamanaka Phenoxyacetic acid derivatives
WO1995021863A1 (fr) 1994-02-10 1995-08-17 Ono Pharmaceutical Co., Ltd. Recepteur de la prostaglandine i¿2?
HU224822B1 (en) 1994-03-10 2006-02-28 Fujisawa Pharmaceutical Co Naphthalene derivatives as prostaglandin i2 agonists, pharmaceutical compns. contg. them and process for preparing them
US5753700A (en) 1994-12-28 1998-05-19 Ono Pharmaceutical Co., Ltd. Naphthyloxyacetic acid derivatives
TW401408B (en) 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism
WO1997005091A1 (fr) 1995-07-26 1997-02-13 Ono Pharmaceutical Co., Ltd. Derives d'acide naphtyloxyacetique et medicaments integrant ces derives comme principes actifs
AUPP029197A0 (en) 1997-11-10 1997-12-04 Fujisawa Pharmaceutical Co., Ltd. Benzocycloheptene derivatives
AUPP109097A0 (en) 1997-12-22 1998-01-22 Fujisawa Pharmaceutical Co., Ltd. Napthalene derivatives

Also Published As

Publication number Publication date
EP1013639A1 (en) 2000-06-28
SG90086A1 (en) 2002-07-23
HUP9904659A3 (en) 2000-12-28
AR029320A1 (es) 2003-06-25
ES2207108T3 (es) 2004-05-16
NO996366D0 (no) 1999-12-21
TWI221834B (en) 2004-10-11
PL337419A1 (en) 2000-07-03
DK1013639T3 (da) 2004-02-09
TR199903310A2 (xx) 2000-10-23
UY25876A1 (es) 2001-07-31
JP3415085B2 (ja) 2003-06-09
JP2000191523A (ja) 2000-07-11
HRP990394A2 (en) 2000-08-31
ATE251125T1 (de) 2003-10-15
KR20000048322A (ko) 2000-07-25
HUP9904659A2 (hu) 2000-11-28
CA2292921A1 (en) 2000-06-23
PT1013639E (pt) 2004-02-27
ID25983A (id) 2000-11-16
NO316171B1 (no) 2003-12-22
HU9904659D0 (en) 2000-02-28
CN1167670C (zh) 2004-09-22
EP1013639B1 (en) 2003-10-01
KR100378335B1 (ko) 2003-03-29
DE69911726T2 (de) 2004-07-29
CA2292921C (en) 2004-08-17
AU6534099A (en) 2000-07-06
NZ501891A (en) 2001-10-26
YU69699A (sh) 2001-12-26
DE69911726D1 (de) 2003-11-06
TR199903310A3 (tr) 2000-10-23
BR9905974A (pt) 2000-09-12
RU2179969C2 (ru) 2002-02-27
PE20001368A1 (es) 2000-12-14
IL133578A0 (en) 2001-04-30
MA26713A1 (fr) 2004-12-20
US6335459B1 (en) 2002-01-01
NO996366L (no) 2000-06-26
AU735640B2 (en) 2001-07-12
CN1266054A (zh) 2000-09-13

Similar Documents

Publication Publication Date Title
RU2629930C2 (ru) Ингибиторы неприлизина
EP0947500B1 (en) Sulfonamide derivatives and drugs containing the same as the active ingredient
JP4271657B2 (ja) マンデル酸誘導体
JP6088047B2 (ja) 一酸化窒素ドナーであるネプリライシン阻害剤
EP1013639B1 (en) Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit
KR20080063321A (ko) 시클로프로필아세트산 유도체 및 그의 용도
KR0148389B1 (ko) 융합된 벤젠옥시아세트산 유도체
AU2002253061B2 (en) Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
US7241784B2 (en) Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
JP4505324B2 (ja) レニンの酵素活性の阻害剤としてのアミド誘導体
IE67507B1 (en) Cyclopentane derivatives process for their production and their pharmaceutical use
EP0719760B1 (en) Naphthalene derivatives and their use as PGE2 agonists and antagonists
JPS5982385A (ja) N−置換−2−(1−イミダゾリル)インド−ル、その製法および該化合物を含有する医薬製剤
JP5384485B2 (ja) ジ(ヘテロ)アリールシクロヘキサン誘導体、それらの製造、それらの使用及びそれらを含む薬剤組成物
US4902698A (en) Benzenesulphonamidopyridyl compounds which are useful as thromboxane A.sub.2
WO2002000648A1 (fr) Derives imidazole ou sels de ces derniers, et medicaments contenant les derives ou les sels
EP0426804B1 (en) 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzene derivatives
JP2588242B2 (ja) ジ‐t‐ブチルフェニルアルキル及びベンジルエーテル
CZ457399A3 (cs) Modulátory receptoru prostaglandinu 12 (IP)
MXPA99011894A (en) Arilcarboxilic and tetra acid derivatives
RU2144533C1 (ru) Производные тетразола, способ их получения и фармацевтические композиции на их основе
WO1992015594A1 (en) Benzamide derivatives
NZ188346A (en) Hydantoin derivatives;intermediates;and pharmaceutical compositions
EP0579731A1 (en) Disubstituted naphthalenes

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees